InspireMD Inc reports results for the quarter ended in December - Earnings Summary

InspireMD

30/03/2023 14:31

* InspireMD Inc  NSPR.OQ  reported a quarterly adjusted loss
of 60
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 84 cents per
share.
    * Revenue fell 25.7% to $1.03 million from a year ago;
analysts
expected $1.00 million. 
    * InspireMD Inc's reported EPS for the quarter was a loss
of 60
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * InspireMD Inc shares had risen by 33.8% this quarter.
    * The company reported a quarterly loss of $4.85 million.
    * Wall Street's median 12-month price target for InspireMD
Inc is
$5.60 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.84          -0.60          Beat
 Sep. 30 2022      -0.73          -0.58          Beat
 Jun. 30 2022      -0.73          -0.59          Beat
 Mar. 31 2022      -0.80          -0.57          Beat